Most GLP-1 pens are designed with appropriate needle lengths (typically 48mm) to achieve subcutaneous delivery when held at a 90-degree angle to the skin

Patient safety guidance should include: Education about expected appetite changes and strategies for maintaining adequate nutrition Monitoring for excessive weight loss or signs of malnutrition Assessment of mental health at follow-up visits Clear instructions to report severe or persistent nausea, vomiting, or neuropsychiatric symptoms Awareness that cognitive effects remain investigational and should not influence prescribing decisions Reporting severe persistent abdominal pain (pancreatitis), right upper quadrant pain/jaundice (gallbladder disease), severe abdominal distension with inability to pass gas or stool (possible ileus), persistent vomiting or signs of dehydration, and new/worsening vision changes (retinopathy) Understanding increased hypoglycemia risk when combined with insulin or sulfonylureas GLP-1 receptor agonists are contraindicated in patients with personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2, and should be used with caution in patients with severe gastrointestinal disease, including gastroparesis

Always consult a licensed healthcare provider before starting or changing weight-loss medication
Examples of Products in the Category (Non-Comparative) Some dietary supplements marketed as "GLP-1 gummies" reference probiotics (including Akkermansia strains), fibers, polyphenols, or botanical extracts
Raw material costs are $185 per 10mg versus $79 per 10mg for semaglutide
More is not always better, and that definitely applies to weight loss despite popular assumptions. Tom Gavin Fact-Checker Tom Gavin joined Everyday Health as copy chief in 2022 after a lengthy stint as a freelance copy editor